c difficile
c difficile
01/24/2020
The FDA has expanded the approval of a drug used for the treatment of C. difficile infection to include pediatric patients aged 6 months and older.
01/24/2020
Hepatitis C
Hepatitis C
09/26/2019
The FDA has expanded the approval of a new option for the treatment of adults and children aged 12 years or older or weighing at least 99 pounds with chronic hepatitis C virus genotypes 1, 2, 3, 4, 5, or 6...
09/26/2019
FDA
FDA
09/13/2019
The NHE3 sodium transport inhibitor was approved for use after results from 2 clinical trials showed increased bowel movements and decreased abdominal pain among individuals with IBS-C.
09/13/2019
Hepatitis C
Hepatitis C
08/29/2019
The FDA issued a drug safety warning after more than 60 individuals experienced liver injury after they received treatment with 1 of 3 medications for hepatitis C virus.
08/29/2019
Ulcerative Colitis
Ulcerative Colitis
07/26/2019
The FDA issued a safety alert after results of a safety clinical trial showed increased risk of blood clots and death with higher dosages of the janus kinase inhibitor.
07/26/2019
Gastroenterology
Gastroenterology
06/08/2016
The FDA has issued a warning of serious and potentially fatal cardiac problems associated with the higher-than-recommended use of the antidiarrheal drug loperamide (Imodium).
06/08/2016